MONTGOMERY, Ala. Lawyers will begin closing
arguments in the trial of the state of Alabama's lawsuit against two
prescription drug companies, Novartis and GlaxoSmithKline.
The lawyers for Alabama are seeking $400 million from the drug companies. The state's attorneys argued the companies committed fraud by causing the state's Medicaid program to pay too much for prescription drugs from 1991 to 2005.
Attorneys for the drug companies say that they did not commit fraud.
The trial is the second on more than 70 lawsuits filed by the state against pharmaceutical companies.